Home/Filings/4/0001127602-21-023109
4//SEC Filing

WHITE ROBERT JOHN 4

Accession 0001127602-21-023109

CIK 0001613103other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 6:29 PM ET

Size

14.7 KB

Accession

0001127602-21-023109

Insider Transaction Report

Form 4
Period: 2021-08-02
WHITE ROBERT JOHN
EVP & President MITG
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-08-02+52,07452,074 total
    Exercise: $131.26From: 2022-08-02Exp: 2031-08-02Ordinary Shares (52,074 underlying)
  • Award

    Performance Share Units

    2021-08-02+15,23715,237 total
    Performance Share Units (15,237 underlying)
  • Tax Payment

    Ordinary Shares

    2021-08-02$131.31/sh4,897$643,02540,674 total
  • Award

    Ordinary Shares

    2021-08-02+6,09546,769 total
  • Award

    Stock Option (Right to Buy)

    2021-08-02+1,0851,085 total
    Exercise: $131.26From: 2022-08-02Exp: 2031-08-02Ordinary Shares (1,085 underlying)
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    1,500
Footnotes (7)
  • [F1]This balance increased by 649 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
  • [F2]The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
  • [F3]These securities are owned by the White Family Legacy Trust. The reporting person is the co-trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
  • [F4]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
  • [F5]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  • [F6]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,237 shares will be issued. The actual number of shares to be issued could range from a low of 3,048 at minimum performance to a high of 30,474 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
  • [F7]Vests on August 2, 2024.

Issuer

Medtronic plc

CIK 0001613103

Entity typeother

Related Parties

1
  • filerCIK 0001726709

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 6:29 PM ET
Size
14.7 KB